5 recruiting, 2 completed, 1 not yet recruiting. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Recruiting 5, Completed 2, Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Type 1 Diabetes (T1D): new trials by email Literature Review of Type 1 Diabetes (T1D) trials Research Report on Type 1 Diabetes (T1D)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems Cadisegliatin 800 mg QD, Placebo - Type 1 Diabetes (T1D) | Phase 2 | Recruiting | vTv Therapeutics | 40 | 2026-09-29 | 2026-11-10 |
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) AMX0035, Placebo - Type 1 Diabetes (T1D), Metabolic Diseases | Phase 2 | Recruiting | University of Washington | 60 | 2026-09-01 | 2026-09-15 |
| Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo Golimumab, Placebo (matching golimumab) - Type 1 Diabetes (T1D) | Phase 2 | Not yet recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 255 | 2026-08-08 | 2026-07-06 |
| Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes CIR-0602K, Placebo - Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus | Phase 2 | Recruiting | University of Virginia | 40 | 2026-02-22 | 2026-02-25 |
| Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus freezedried autologous encapsulated fecal microbiota transplantation, placebo matching capsule without microbial content - Type 1 Diabetes Mellitis, Type 1 Diabetes (T1D) | Phase 2 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 110 | 2025-09-01 | 2025-07-24 |
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Recruiting | Otsuka Pharmaceutical Factory, Inc. | 13 | 2025-06-10 | 2026-08-21 |
| Lactobacillus Johnsonii Supplementation in Adults With T1D L. johnsonii Probiotic, Placebo Capsule - Type 1 Diabetes (T1D) | Phase 2 | Completed | University of Florida | 46 | 2020-02-01 | 2026-05-18 |
| Lactobacillus Johnsonii in Children and Adolescents With T1D L. johnsonii Probiotic, Placebo Capsule - Type 1 Diabetes (T1D) | Phase 2 | Completed | University of Florida | 30 | 2019-10-10 | 2026-05-06 |
Diabetes Mellitus, Type 1 (8) · Autoimmune Diseases (2) · Glucose Metabolism Disorders (2) · Immune System Diseases (2) · Metabolic Diseases (2) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Hypoglycemia (1) · Insulin Resistance (1) · Ketosis (1) · Nutritional and Metabolic Diseases (1)
Diabetes Mellitus (7) · Endocrine System Diseases (7) · Nutritional and Metabolic Diseases (7) · Autoimmune Diseases (6) · Glucose Metabolism Disorders (6) · Immune System Diseases (6) · Metabolic Diseases (6) · Acid-Base Imbalance (1) · Acidosis (1) · Hyperinsulinism (1)
Sodium Chloride (1) · TTP399 (1) · golimumab (1) · sodium phenylbutyrate and taurursodiol (1)
University of Florida (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Otsuka Pharmaceutical Factory, Inc. (1) · University of Virginia (1) · University of Washington (1) · vTv Therapeutics (1)
United States (7) · Netherlands (2)
Michael Haller (2) · Jason Gaglia, MD (1) · Maria Alba, MD (1) · Petter M Bjornstad, MD (1) · William B. Horton, MD (1)
R01DK121130 (1)